SPRY
ARS Pharmaceuticals Inc

2,322
Mkt Cap
$945.98M
Volume
848,573.00
52W High
$18.90
52W Low
$6.66
PE Ratio
-11.77
SPRY Fundamentals
Price
$9.54
Prev Close
$9.57
Open
$9.59
50D MA
$9.38
Beta
1.21
Avg. Volume
2.13M
EPS (Annual)
$0.0781
P/B
6.39
Rev/Employee
$557,181.25
Loading...
Loading...
News
all
press releases
Franklin Resources Inc. Sells 28,789 Shares of ARS Pharmaceuticals, Inc. $SPRY
Franklin Resources Inc. trimmed its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 1.5% during the second quarter, according to the company in its most recent disclosure...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Raised to Hold at Zacks Research
Zacks Research upgraded shares of ARS Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Thursday...
MarketBeat·6d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Trading Up 12.6% - Here's What Happened
ARS Pharmaceuticals (NASDAQ:SPRY) Trading Up 12.6% - Still a Buy...
MarketBeat·7d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Sets New 1-Year Low After Insider Selling
ARS Pharmaceuticals (NASDAQ:SPRY) Hits New 1-Year Low After Insider Selling...
MarketBeat·11d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) COO Brian Dorsey Sells 21,828 Shares
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) COO Brian Dorsey sold 21,828 shares of the business's stock in a transaction that occurred on Thursday, November 13th. The shares were sold...
MarketBeat·12d ago
News Placeholder
Insider Selling: ARS Pharmaceuticals (NASDAQ:SPRY) Insider Sells 166,380 Shares of Stock
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) insider Justin Chakma sold 166,380 shares of ARS Pharmaceuticals stock in a transaction dated Wednesday, November 12th. The shares were sold...
MarketBeat·12d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Insider Justin Chakma Sells 166,380 Shares
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) insider Justin Chakma sold 166,380 shares of the company's stock in a transaction on Wednesday, November 12th. The stock was sold at an...
MarketBeat·14d ago
News Placeholder
ARS Pharmaceuticals, Inc. $SPRY Shares Sold by Quinn Opportunity Partners LLC
Quinn Opportunity Partners LLC lessened its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 59.7% in the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·15d ago
News Placeholder
Q3 EPS Estimates for ARS Pharmaceuticals Cut by Roth Capital
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) - Analysts at Roth Capital dropped their Q3 2027 earnings estimates for ARS Pharmaceuticals in a research report issued on Monday, November 10th...
MarketBeat·16d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Gap Up - What's Next?
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Gap Up - What's Next...
MarketBeat·18d ago

Latest SPRY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.